Financial Conflict Of Interest FDA Surveillance Must Increase - Henney
This article was originally published in The Tan Sheet
Executive Summary
Increased surveillance of financial conflict of interest is necessary to guard against bias or the perception of bias, FDA Commissioner Jane Henney, MD, indicated at an HHS meeting on human subject protection and financial conflict of interest Aug. 15 at the National Institutes of Health.